Lexeo Therapeutics

heart monitor

Biotech

Lexeo locks in pivotal trial plan as gene therapy data accrue

Lexeo linked the gene therapy to improvements on outcomes it plans to use as co-primary endpoints in a registrational trial.

Nick Paul Taylor Apr 7, 2025 9:37am

heart beat cardiogram pulse cardio

Lexeo links gene therapy to improvements in rare heart disease

Jul 15, 2024 9:46am

parachute snow mountains

Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders

Feb 9, 2024 9:30am

IPO initial public offering Wall Street

Lexeo drops share price at last minute to raise $100M IPO

Nov 3, 2023 8:19am

Wall Street stock exchange new York shares market

Two biotechs go public while Apnimed bides its time

Oct 2, 2023 11:02am

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am